Generation bio to present at the jmp securities life sciences conference

Cambridge, mass., may 09, 2023 (globe newswire) -- generation bio co. (nasdaq:gbio), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that matt norkunas, m.d., chief financial officer, will present at the jmp securities life sciences on tuesday, may 16, 2023 at 1:00 p.m. est in new york.

GBIO Ratings Summary

GBIO Quant Ranking